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A B S T R A C T
Oxidative stress attributable to the activation of a Nox2-containing NADPH oxidase is involved in the
development of vascular diseases and in aging. However, the mechanism of Nox2 activation in normal aging
remains unclear. In this study, we used age-matched wild-type (WT) and Nox2 knockout (KO) mice at 3–4
months (young); 11–12 months (middle-aged) and 21–22 months (aging) to investigate age-related metabolic
disorders, Nox2 activation and endothelial dysfunction. Compared to young mice, middle-aged and aging WT
mice had signiﬁcant hyperglycaemia, hyperinsulinaemia, increased systemic oxidative stress and higher blood
pressure. Endothelium-dependent vessel relaxation to acetylcholine was signiﬁcantly impaired in WT aging
aortas, and this was accompanied by increased Nox2 and ICAM-1 expressions, MAPK activation and decreased
insulin receptor expression and signaling. However, these aging-associated disorders were signiﬁcantly reduced
or absent in Nox2KO aging mice. The eﬀect of metabolic disorder on Nox2 activation and endothelial
dysfunction was further conﬁrmed using high-fat diet-induced obesity and insulin resistance in middle-aged
WT mice treated with apocynin (a Nox2 inhibitor). In vitro experiments showed that in response to high glucose
plus high insulin challenge, WT coronary microvascular endothelial cells increased signiﬁcantly the levels of
Nox2 expression, activation of stress signaling pathways and the cells were senescent, e.g. increased p53 and
β–galactosidase activity. However, these changes were absent in Nox2KO cells. In conclusion, Nox2 activation in
response to aging-associated hyperglycaemia and hyperinsulinaemia plays a key role in the oxidative damage of
vascular function. Inhibition or knockout of Nox2 preserves endothelial function and improves global
metabolism in old age.
1. Introduction
Age is recognized as a major risk factor for cardiovascular diseases.
High prevalence of obesity and insulin resistance in an aging population
has led to a rapid increase in type-2 diabetes and cardiovascular
diseases [1–3]. An early feature in the development of metabolic and
cardiovascular diseases is the progressive endothelial dysfunction
attributable to increased reactive oxygen species (ROS) production by
a Nox2-containing NADPH oxidase [2,4–8]. Oxidative stress causes
DNA damage, alters transcriptional machinery and promotes inﬂam-
matory gene expressions. All these are key factors that further accel-
erate vascular aging [2].
NADPH oxidase is a multicomponent enzyme. The catalytic subunit
of NADPH oxidase has been found to have 7 isoforms (Nox1-5, and
Duox 1–2) [9,10]. Among these Nox isoforms, Nox2 is highly expressed
in both inﬂammatory phagocytic cells and vascular endothelial cells
[9,10]. Unlike the other Nox isoforms, Nox2 requires p22phox and
several regulatory subunits i.e. p40phox, p47phox p67phox and rac1 for
O2.- production [11]. In response to stimuli, such as high glucose,
oxidized LDL and inﬂammatory cytokines, endothelial Nox2 is acti-
vated and produces excessive levels of ROS, which outstrips the
endogenous antioxidant defense and causes oxidative damage to the
endothelium and the organs [7,8]. Transgenic mice with endothelial-
speciﬁc Nox2 overexpression had high levels of ROS production and
ERK1/2 activation in the endothelium [7], and there is a close
relationship between the levels of endothelial oxidative stress and the
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degree of insulin resistance and cardiovascular disorders found in
experimental animals and in humans [4,6,12]. However, the mechan-
ism of Nox2 activation in normal aging remains unclear.
In this study, we used littermates of age-matched wild-type (WT)
and Nox2 knockout (Nox2KO) mice in young (3–4 m); middle-aged
(11–12 m) and old age (21–22 m) to investigate the mechanism of
aging-associated Nox2 activation and global oxidative stress. In parti-
cular, we examined the relationship between the levels of aging-related
glucose metabolic disorders and endothelial Nox2 activation in aorta
inﬂammation, decline of insulin receptor expression and endothelial
dysfunction. The critical role of metabolic disorder in Nox2 activation
and endothelial dysfunction was further examined using a model of
high-fat diet-induced obesity and insulin resistance in middle-aged WT
mice treated with or without apocynin (a Nox2 inhibitor). We also
examined the mechanisms of high glucose and insulin-induced Nox2
activation and redox-signaling in endothelial cell senescence and
apoptosis using coronary microvascular endothelial cells (CMEC) iso-
lated from WT and Nox2KO mice. Our study for the ﬁrst time
demonstrated a crucial role of global Nox2 activation in response to
aging associated glucose metabolic disorders (i.e. hyperglycaemia and
hyperinsulineamia) causing inﬂammation and oxidative damage of
endothelial function and insulin receptor function in major vessels.
Inhibition or knockout of Nox2 helps to preserve endothelial function
and improves global metabolism in old age.
2. Materials and methods
2.1. Reagents
Polyclonal antibodies against Nox1, Nox2, Nox4, p22phox, p40phox,
p47phox, p67phox, rac1, insulin receptors (IRα and IRβ) were from Santa
Cruz Biotechnology. Antibodies to phospho-ERK1/2, phospho-
p38MAPK, phospho-JNK and phospho-Aktser473 were from Cell
Signaling Technology. DHE (dihydroethidium) and 5-(and 6)-chloro-
methyl-2',7'-dichlorodihydroﬂuorescein diacetate (DCF) were from
Invitrogen (UK). All other reagents and chemicals were from Sigma
unless stated otherwise.
2.2. Animals
All studies were performed in accordance with the protocols
approved by the Home Oﬃce under the Animals (Scientiﬁc
Procedures) Act 1986, UK. Nox2 knockout mice on a C57BL/6J
background were originally obtained from Jackson Laboratory, USA.
These mice were generated by insertion of an expression cassette for
neomycin resistance into exon 3 of the Nox2 gene (Cybb) and attaching
a ﬂanking herpes thymidine kinase gene [13]. Nox2KO mice lack
phagocyte superoxide production and manifest an increased suscept-
ibility to infection. Littermates of WT and Nox2KO mice were bred in
our institution from heterozygotes and genotyped. Animals were
housed under standard conditions with a 12:12 light dark cycle and
food and water were available ad libitum. Male mice were randomly
grouped and used at young (3–4 m), middle age (11–12 m) and old age
(21–22 m). A total of 12–15 mice were used per group. Body weights
were measured monthly. The measurement of food intake was for a
period of 3 days while the animals were individually housed and
repeated every month.
2.3. High-fat diet-induced obesity and insulin resistance in middle-aged
mice treated with or without apocynin
Littermates of WT and Nox2KO male mice at 8 m of age were
randomly assigned (n=10/per group) to a high-fat diet (HFD group):
45% kcal fat, 20% kcal protein, and 35% kcal carbohydrate (Special
Diets Services, UK), or a normal chow diet (control group): 3% kcal fat,
25.9% kcal protein, and 64.8% kcal carbohydrate (LabDiet Ltd., UK) for
16 weeks. Apocynin was supplied in drinking water (5 mM). Food
intake and body weights were measured as described above. Mice were
used at the age of 12 m.
2.4. Metabolic measurements and intraperitoneal glucose tolerance test
(IPGTT)
These were performed as described previously [8]. Serum glucose
was measured at 9 a.m. after 8 h of fasting using a blood glucose meter
(Accu-Chek, UK). Fasting plasma insulin was measured using a mouse
insulin enzyme-linked immunosorbent assay kit (Mercodia Developing
Diagnostic, Sweden). Fasting serum cholesterol, FFA, triglyceride, and
high-density-lipoprotein (HDL) cholesterol were measured by enzy-
matic colorimetric assays using an ILab 650 Chemistry System. LDL
cholesterol was calculated as the diﬀerence between total and HDL
cholesterol concentrations based on the Friedewald equation [14]. For
the IPGTT, mice were fasted for 8 h before an intraperitoneal injection
(IP) of glucose (2 g kg−1 body weight) was administrated. Blood
glucose was then measured at 15, 30, 60 and 120 min after injection.
2.5. Blood pressure (BP) and endothelial function assessments
These were performed exactly as described previously [8]. BP was
measured by a computer controlled non-invasive tail-cuﬀ BP system
(Kent Scientiﬁc Corporation, USA) on conscious mice at 10 am, and
measurements were recorded by the CODA™ program. The mean of at
least 6 successful recordings was used for each mouse. For the
assessment of endothelial function, freshly excised thoracic aortic rings
(3–4 mm in length) were suspended in an organ bath (ML0146/C-V, AD
Instrument Ltd) at 37 °C containing 10 ml of Krebs-Henseleit solution
(in mmol/L: NaCl 119, KCl 4.7, KH2PO4 1.2, MgSO4 1.2, CaCl2 2.5,
NaHCO3 25, glucose 11.1, pH 7.4) gassed with 95% O2/5% CO2. The
cumulative dose response to phenylephrine (PE) (1 nmol/L to 10 μmol/
L) was assessed ﬁrst. After washing and re-equilibration, relaxation
responses to sodium nitroprusside (SNP, 0.1 nmol/L to 1 μmol/L) or
acetylcholine (Ach, 1 nmol/L to 10 μmol/L) were assessed in rings pre-
constricted to ∼70% of their maximal PE-induced tension. Relaxation
was expressed as the percentage of pre-constricted tension. Some
experiments were performed in the presence of tiron (10 mmol/L) or
the nitric oxide synthase (NOS) inhibitor, Nω-Nitro-L-arginine methyl
ester (L-NAME, 100 µmol/L).
2.6. Coronary microvascular endothelial cell (CMEC) isolation
CMECs were isolated from the hearts of middle-aged (11–12 m) WT
and Nox2KO mice according to the method reported previously [15].
Six hearts were used for each CMEC isolation. CMECs were cultured in
DMEM supplemented with 10% FBS, EC growth supplement (30 µg/
ml), epidermal growth factor (10 ng/ml), vascular endothelial growth
factor (0.5 ng/ml), ascorbic acid (1 µg/ml), hydrocortisone (1 µg/ml),
L-glutamine (2 mmol/L), penicillin (50 U/ml) and streptomycin (50 µg/
ml). CMECs were used at passage 2.
2.7. In situ detection of senescence-associated β-galactosidase (SAβG)
activity
The SAβG activity (a cell senescence marker) in cultured CMECs
was performed as described previously [16]. Brieﬂy, cells were cultured
on chamber slides and treated according to the experimental design.
After ﬁxation with 1% ice-cold paraformaldehyde and washing in PBS,
cells were incubated with freshly prepared staining buﬀer containing
40 mmol/L citric acid/sodium (pH 6.0), 0.15 mol/L NaCl, 2 mmol/L
MgCl2, 5 mmol/L potassium ferrocyanide, 1 mg/ml X-gal (5-bromo-4-
chloro-3-indolyl β-D-galactoside). The SAβG positive cells (blue) were
examined microscopically at ×200 magniﬁcation and counted.
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2.8. TUNEL assay
The TUNEL assay was performed as described previously [17].
Brieﬂy, endothelial cells were cultured onto the chamber slide, and
stimulated with high glucose plus insulin for 24 h. The cells were then
washed and ﬁxed in 2% methanol-free formaldehyde/PBS solution, and
treated with 0.2% Triton® X-100/PBS solution for 5 min. The TUNEL
assay was performed using the DeadEnd ﬂuorometric technique
(Promega, UK) following the protocol of the manufacturer and visua-
lised under ﬂuorescence microscopy.
2.9. ROS measurement
The O2.- production by tissue (or cell) homogenates was measured
by three complementary techniques: lucigenin (5 µmol/L)-chemilumi-
nescence in tissue homogenates (Lumistar, BMG); DHE (2 µmol/L)
ﬂuorescence on tissue sections or DCF ﬂuorescence for cells as
described previously [18] and superoxide dismutase (SOD, 200 U/
ml)-inhibitable cytochrome c reduction assay [19]. The speciﬁcity of
detection of O2.- was conﬁrmed by adding tiron (10 mmol/L), a non-
enzymatic O2.- scavenger. The enzymatic sources of O2.- production
were identiﬁed using inhibitors targeting NOS (L-NAME 100 μmol/L),
the mitochondrial complex-1 enzymes (rotenone, 50 μmol/L), xanthine
oxidase (oxypurinol, 250 μmol/L), ﬂavo-proteins (diphenyleneiodo-
nium, DPI, 20 μmol/L), or SOD (200 U/ml) before O2.- measurement.
DHE (or DCF) images were captured digitally and acquired using an
Olympus BX61 ﬂuorescence microscope. The ﬂuorescence intensity was
quantiﬁed from at least 5 random ﬁelds (269.7×269.2 µm) per section
with 3 sections/sample and 6 animals/group. Nitric oxide (NO)
production was assessed by measuring the concentration of serum
nitrite, which is one of the primary stable and nonvolatile breakdown
products of NO using the Griess assay kit from Promega UK.
2.10. Immunoblotting
This was performed exactly as described previously [8,20]. The
images were captured digitally using a BioSpectrum AC imaging system
(UVP, UK), and the optical densities of the protein bands were
normalized to the loading control bands and quantiﬁed.
2.11. Immunoﬂuorescence microscopy
The experiments were performed exactly as described previously
[8,20]. Primary antibodies were used at 1:250 dilution and biotin-
conjugated anti-rabbit or anti-goat (1:1000 dilution) were used as
secondary antibodies. Speciﬁc binding of antibodies was detected by
extravidin-FITC or streptavidin-Cy3. Normal rabbit or goat IgG (5 µg/
ml) was used instead of primary antibody as a negative control. Images
were acquired with an Olympus BX61 ﬂuorescence microscope system.
Fluorescence intensities were quantiﬁed as described above.
2.12. Statistical analysis
Statistical analysis was performed using one-way or two-way
analysis of variance (ANOVA) followed by Bonferroni post-hoc tests
except where it was speciﬁed in the ﬁgure legend. The data were from
at least 9–13 mice/group and expressed as mean± SD except where
speciﬁed in the ﬁgure legend. P<0.05 was considered statistically
signiﬁcant.
3. Results
3.1. Aging-associated metabolic disorders and insulin resistance
There was no signiﬁcant diﬀerence in the amount of food intake,
heart weight/body weight ratios and serum nitrite levels (an indicator
of NO metabolism) between age groups of WT and Nox2KO mice
(Fig. 1A). At young age (3–4 m), there was no signiﬁcant diﬀerence
between WT and Nox2KO mice for all of the parameters examined
(Fig. 1A-B). However, WT mice had signiﬁcantly greater body weight,
epididymal fat weight and blood pressure starting at middle age
(11–12 m) and progressing to old age (21–22 m). Compared to age-
matched WT mice, age-related increases in body and epididymal fat
weights were signiﬁcantly reduced in Nox2KO mice. Blood pressure
was well maintained in Nox2KO mice without any signiﬁcant diﬀer-
ences between age groups (Fig. 1A).
The levels of fasting serum non-essential free fatty acids (NEFA) and
triglyceride were well maintained without signiﬁcant age-related
diﬀerences between WT and Nox2KO mice (Fig. 1B). However, the
levels of fasting serum total cholesterol, LDL, glucose and insulin
increased as age progressed and were statistically signiﬁcant at old-
age in comparison to young mice in WT mice, but not in Nox2KO mice.
Insulin resistance in aging WT mice was further conﬁrmed by glucose
tolerance tests (Fig. 1C).
3.2. Knockout Nox2 abolished aging-associated increase in ROS production
in multiple organs
Age-related systemic oxidative stress was examined by measuring
the levels of NADPH-dependent O2.- production using organ homo-
genates by lucigenin (5 µM)-chemiluminescence (Fig. 2). In WT mice,
the levels of O2.- production in diﬀerent organs varied with the highest
levels found in the bone marrow and the liver. There were signiﬁcant
increases in the levels of O2.- production starting at middle age and
progressing to old-age in the heart, lung, liver, kidney, aorta, spleen,
fat, brain and the bone marrow (except skeletal muscles) of WT mice,
but not in the organs of Nox2KO mice. In fact, the Nox2KO bone
marrow, spleen and fat tissue had very little (just detectable) O2.-
production. The skeletal muscle produced low levels of O2.- production
without signiﬁcant diﬀerence between age groups of both WT and
Nox2KO mice.
3.3. Aging-associated endothelial dysfunction in WT but not in Nox2KO
mice
The vascular function was examined ex vivo using freshly isolated
aortic sections in an organ bath. There were no signiﬁcant diﬀerences in
the vessel contractile responses to phenylephrine (PE) between WT and
Nox2KO mice of all age groups (Figs. 3A and 3E). At young age, there
were no signiﬁcant diﬀerences in endothelium-dependent vessel relaxa-
tion to acetylcholine (Ach) between WT and Nox2KO mice. However,
the endothelium-dependent vessel relaxation response to acetylcholine
started to reduce at middle-age and was signiﬁcantly impaired at old
age (Fig. 3B), which could be corrected back to levels of the young mice
by adding tiron (an O2.- scavenger) suggesting a role for O2.- (Fig. 3B).
The endothelium-dependent vessel relaxation to Ach (Fig. 3B) was
completely blocked by adding L-NAME, an inhibitor of endothelial
nitric oxide synthase (eNOS) indicating that Ach-induced vessel relaxa-
tion was depending on endothelial release of NO (Fig. 3 C). However,
the smooth muscle relaxation response to SNP (a NO donor) was not
aﬀected by age (Fig. 3D). The signiﬁcance in reduced endothelium-
dependent response to Ach in WT aging mice was further conﬁrmed by
EC50 values (Fig. 3E).
3.4. Aging-associated activation of Nox2, stress signaling pathways, VCAM-
1 expression and damage of insulin receptor expression in aortas
To further deﬁne a role for Nox2 in the oxidative regulation of aging
aorta function, we examined the aorta expression of Nox subunit by
Western blot (Fig. 4A). Compared to young WT aortas, there were
signiﬁcant increases in the levels of Nox2, p22phox, p40phox, p47phox,
p67phox and rac1/2 expressions, and a signiﬁcant decrease in Nox4
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expression in aging WT aortas. However, there was no signiﬁcant
diﬀerence in the levels of expressions of p22phox, p40phox, p47phox,
p67phox and rac1/2 between young and aging Nox2KO aortas; instead,
aging Nox2KO aortas had a signiﬁcant increase in Nox4 expression as
compared to young Nox2KO controls (Fig. 4A). Although the levels of
Nox1 expression showed a pattern of age-related increase, the diﬀer-
ence between young and aging groups was not statistically signiﬁcant
for both WT and Nox2KO mice.
We then examined the diﬀerence in redox-sensitive ERK1/2,
p38MAPK and JNK phosphorylation in aortic samples using phosphor-
ylation-speciﬁc monoclonal antibodies. The levels of total protein
detected in the same samples were used as loading controls (Fig. 4B).
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Compared to young WT aortas, the levels of ERK1/2 phosphorylation
were increased signiﬁcantly, whereas the levels of p38MAPK phosphor-
ylation were decreased signiﬁcantly in aging WT aortas (Fig. 4B).
However, there was no signiﬁcant diﬀerence in ERK1/2 and p38MAPK
phosphorylation between young and aging aortas of Nox2KO mice. The
levels of phosphorylated JNK were very low and showed no signiﬁcant
change between age groups of WT and Nox2KO aortas. Putting every-
thing together, our data strongly suggest a crucial role for age-
associated Nox2 activation in the activation of redox signaling path-
ways in aging WT aortas.
To explore any relationship between Nox2-derived oxidative stress,
inﬂammation and vascular insulin resistance in aging aortas, we
examined the levels of expression of vascular cell adhesion molecule
1 (VCAM-1, an inﬂammation marker), the expression of insulin
receptor and the levels of AKT phosphorylation (a key molecule
involved in the insulin signaling pathway) in aortic homogenates by
Western blot (Fig. 4C). There was no signiﬁcant diﬀerence in the
expression of these molecules at the young age between WT and
Nox2KO aortas. However, there was a signiﬁcant increase in the
VCAM-1 expression in aging WT aortas, which was accompanied by
signiﬁcant decreases in insulin receptor (both IRα and IRβ) expression
and AKT phosphorylation in comparison to the levels in young WT
aortas, (Fig. 4C). These changes were absent in Nox2KO aging aortas.
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3.5. In situ detection of ROS production, Nox2 expression, inﬂammation
and oxidative damage of insulin receptor expression in aging aortas
Increased ROS production in the aging aorta was further examined
in situ by DHE ﬂuorescence on aortic sections (Fig. 5A). Tiron was used
to conﬁrm the detection of O2.-. Compared to young WT vessels, there
was a signiﬁcant increase in DHE ﬂuorescence throughout the aortic
wall of WT aging mice, which was signiﬁcantly reduced by adding
tiron. In contrast, there was no signiﬁcant increase in DHE ﬂuorescence
in Nox2KO aging aortas as compared to young Nox2KO aortas.
Fig. 4. Western blot detection of NADPH oxidase subunit expression, MAPK activation, VCAM-1 and insulin receptor expressions and AKP activation in aortas. A) NADPH oxidase subunit
expression. Optical densities (OD) of protein bands were quantiﬁed and normalized to α-tubulin detected in the same sample. B) MAPK phosphorylation. The phospho-bands were
quantiﬁed and normalized to the total levels of the same protein detected in the same samples. C) VCAM-1 and insulin receptor expression and Akt phosphorylation. Protein bands were
quantiﬁed and normalized to α-tubulin detected in the same sample. *P< 0.05 for indicated values versus 3–4 m values in the same genetic group. n =9 mice/group.
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Fig. 5. Immunoﬂuorescence detection of ROS production and the expressions of Nox2, inﬂammatory markers and insulin receptor in aorta walls. A) Aorta ROS production detected by in
situ DHE ﬂuorescence (red). Tiron was used to conﬁrm the detection of O2.-. B) Nox2 expression (green). The endothelium was labelled with CD31 (red). Endothelial expression of Nox2
was indicated by the yellow ﬂuorescence. C) Aorta expression of inﬂammatory marker, ICAM-1 (red) and CD45 positive (green) inﬂammatory cell inﬁltration. D) Insulin receptor (IRα)
expression. Nuclei were labelled by DAPI (blue colour) to visualize the vessel wall. *P<0.05 for indicated values versus 3–4 m values in the same genetic group. †P<0.05 for indicated
values versus WT values from the same age group. n =9 mice/group.
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In order to conﬁrm an increased endothelial Nox2 expression in
aging aortas, we labelled the endothelium with CD31 (an endothelial
cell marker, red ﬂuorescence) and detected Nox2 expression (green
ﬂuorescence) in aortic sections. Nuclei were labelled with DAPI (blue
ﬂuorescence) to visualize the cells (Fig. 5B). Nox2 was weakly
detectable in WT young aortas and was mainly present in the
adventitia. Compared to WT young aortas, there was a signiﬁcant
increase in endothelial Nox2 expression in aging WT aortas as indicated
by the yellow ﬂuorescence (Fig. 5B).
Endothelial inﬂammation was further examined by the expression
of intercellular adhesion molecule-1 (ICAM-1, red) and inﬁltrating
leucocytes (labelled with CD45, green) (Fig. 5C). At young age, the
level of ICAM-1 expression was low and mainly detected in the
endothelium and adventitia without signiﬁcant diﬀerence between
WT and Nox2KO mice; CD45-positive cells were almost undetectable
in the aortic wall of both WT and Nox2KO young mice. However, at old
age, there was a remarkable increase in the levels of ICAM-1 expression
in the endothelium of WT aortas, and this was accompanied by CD45-
positive leucocyte inﬁltration throughout the vessel wall predominately
around the endothelium as indicated by the yellow ﬂuorescence
(Fig. 5C). However, these inﬂammatory changes were signiﬁcantly
reduced in Nox2KO aging aortas.
We then examined the aorta insulin receptor expression (Fig. 5D).
Insulin receptor α was detected throughout the aortic wall without
signiﬁcant diﬀerence at young age between WT and Nox2KO mice.
Compared to young WT aortas, the expression of insulin receptor α was
reduced signiﬁcantly in WT aging aortas mainly in the endothelium and
the media. However, insulin receptor expression was well preserved in
aging Nox2KO aortas.
3.6. Metabolic disorder-induced Nox2 activation and oxidative damage of
endothelial function in high fat diet (HFD)-induced obesity and insulin
resistance treated with or without apocynin
High-fat diet-induced mouse model of obesity and insulin resistance
has been shown to display an accelerated aging phonotype and
increased levels of oxidative stress/damage in organ function [21].
Therefore, it would be a good model for us to examine the eﬀects of
metabolic disorders on Nox2 activation and endothelial dysfunction.
Compared to control chow diet-fed mice, WT mice under HFD increased
signiﬁcantly the body weight and blood pressure together with high
levels of fasting serum glucose and insulin (Fig. 6A). However, these
changes were signiﬁcantly reduced after apocynin treatment.
We then examined the Nox2 expression in aortas by immunoﬂuor-
escence. Compared to control vessels, HFD up-regulated signiﬁcantly
the Nox2 expression (green colour) in the aorta wall mainly in the
endothelium (labelled by CD31 in red) and the adventitia (Fig. 6B).
Apocynin treatment had no statistically signiﬁcant eﬀect on aorta Nox2
expression (Fig. 6B, right panel). Aortas of HFD mice had signiﬁcantly
higher levels of NADPH-dependent O2.- production as examined by both
lucigenin-chemiluminescence and SOD-inhibitable cytochrome c reduc-
tion assay, and these were signiﬁcantly inhibited by apocynin-treat-
ment (Fig. 6C). The endothelium-dependent vessel relaxation to
acetylcholine was attenuated in HFD WT aortas, and this was well
preserved in HFD mice treated with apocynin (Fig. 6D). The impair-
ment of endothelium-dependent vessel relaxation to acetylcholine in
HFD WT aorta was inhibited by MnTMPyP (a cell permeable SOD
mimic), which further conﬁrmed the role of ROS in mediating HFD-
induced endothelial dysfunction (Fig. 6D, right panel).
3.7. High glucose and insulin-induced endothelial Nox2 activation and
oxidative signaling in endothelial cell senescence and apoptosis
Hyperglycaemia and hyperinsulinaemia-induced Nox2 activation
and stress signaling in endothelial aging was further examined using
CMECs isolated from middle-aged (11–12 m) WT and Nox2KO mice.
Cells were challenged with high glucose (25 mmol/L) plus insulin
(1.2 nmol/L) for 24 h and examined for NADPH-dependent O2.- produc-
tion (Fig. 7A). Compared to vehicle-stimulated control cells, high
glucose/insulin signiﬁcantly increased the levels of O2.- production in
WT cells (Fig. 7A, left panel), and this was inhibited signiﬁcantly by
tiron and DPI (a ﬂavoprotein inhibitor), but not by L-NAME (NOS
inhibitor), rotenone (mitochondria complex 1 enzyme inhibitor) nor
oxypurinol (xanthine oxidase inhibitor) (Fig. 7A, right panel). Increased
ROS production by WT CMECs was accompanied by signiﬁcant
increases in the levels of Nox2 expression, ERK1/2 phosphorylation
and p53 (cell apoptosis-related gene product) expression (Fig. 7B). In
contrast, Nox2KO CMECs failed ROS response to high glucose/insulin
challenge (Fig. 7A, middle panel), and the ERK1/2 and p53 activation
were inhibited or absent in Nox2KO cells (Fig. 7B). The role of Nox2-
derived ROS in mediating endothelial senescence and apoptosis was
examined by SAβG activity and TUNEL assay, respectively (Fig. 7C). In
comparison to WT control cells, high glucose/insulin challenge sig-
niﬁcantly increased the levels of intracellular ROS production detected
by DCF ﬂuorescence (green, left panels), and this was accompanied by
signiﬁcant increases in Nox2 expression (green, middle left panels), cell
senescence (blue, middle right panels) and cell apoptosis (yellow, right
panels). However, these changes were signiﬁcantly inhibited in Nox2-
KO cells.
4. Discussion
Aging is recognized as a normal biological process and is often
associated with progressive oxidative stress in multiple organs [2,3].
Although accumulating evidence has suggested that Nox2-derived ROS
are involved in the oxidative damage of vascular function, the
mechanisms (or factors) of Nox2 activation in normal aging remain
unclear. This report using WT and Nox2KO mice of three distinct age
groups (3–4 m, 11–12 m and 21–22 m) combined with a range of
cellular and molecular approaches, revealed for the ﬁrst time a crucial
role for metabolic disorders (in particular hyperglycaemia and hyper-
insulinaemia secondary to insulin resistance) in systemic Nox2 activa-
tion, vascular inﬂammation and endothelial dysfunction in aging.
One of the common pathophysiological manifestations in human
aging is a declining regulation of glucose metabolism [3,22]. In
accordance with previous reports, we found that WT mice developed
hyperglycaemia and hyperinsulinaemia starting in middle age and
worsening at old age, when the levels of fasting serum glucose and
insulin were nearly two-fold and four-fold of the levels of WT young
mice, respectively. The novelty of the current study is that we showed a
global Nox2 activation (not restricted in the endothelium) in response
to aging-associated hyperglycaemia and hyperinsulinaemia as demon-
strated by an age-related increase in the levels of Nox2-derived ROS
production in several vital organs of WT mice including the heart,
aorta, lung, spleen, kidney, brain, and bone marrow. We also demon-
strated a positive feedback loop between progressive Nox2 activation in
a high glucose/insulin environment and Nox2-derived oxidative stress
causing further damage to the global metabolism in aging. Knockout of
Nox2 or inhibiting Nox2 not only reduced the levels of aging-associated
ROS production in these organs but also prevented metabolic syndrome
and preserved endothelial function in old age.
Mouse aorta is a well-established and mostly used organ for studying
metabolic or aging-related large vessel dysfunction [23]. An important
discovery in the current study is that reduced IR expression and IR
signaling (Akt phosphorylation) in aging aortas together with inﬂamma-
tion and oxidative damage of endothelial function. Using three comple-
mentary techniques (lucigenin-chemiluminescence, in situ DHE ﬂuores-
cence and SOD-inhibitable cytochrome c reduction assay), we demon-
strated that aging aortas produced ~2 folds more ROS than young
controls and this was accompanied by profound endothelial dysfunction
and high blood pressure. The impaired endothelial dependent vessel
relaxation was related to oxidative stress because addition of superoxide
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scavenger (tiron or MnTMPyP) in the organ bath restored the endothelial
function. Furthermore, knockout of Nox2 completely abolished aorta
ROS production and restored IR expression and signaling in old age. The
crucial role of metabolic disorder-induced Nox2 activation and oxidative
damage of endothelial function was further demonstrated using an
accelerated aging model of HFD-induced obesity and insulin resistance
of mice at 12 m of age, which is equivalent to a human of ~50 years old
when most metabolic and vascular diseases occur [1,21,23]. Once again
we showed that inhibition of Nox2 activity using apocynin signiﬁcantly
reduced HFD-induced high blood pressure and aorta oxidative stress and
preserved endothelial function.
High glucose and insulin are potent activators of the endothelial
Nox2 enzyme [3,4]. The current study extends our understanding of
insulin resistance in vascular aging by showing that high glucose/
insulin via Nox2 stress signaling pathways promotes premature en-
dothelial cell aging. In response to high glucose and insulin challenge,
WT endothelial cells increased ROS production, which resulted in
ERK1/2 activation, p53 expression and endothelial cell senescence
and apoptosis. Knockout of Nox2 not only abolished high glucose/
insulin-induced ROS production but also protected endothelial cells
from premature senescence and apoptosis. Although the relevance of in
vitro senescence to organismal aging remains unclear, our in vitro data
are in support of our in vivo observation that Nox2 plays a crucial role
in glucose metabolic disorder-associated oxidative damage of endothe-
lial cells and vascular aging.
The catalytic subunit of NADPH oxidase has 7 isoforms viz. Nox1-5,
and Duox1-2 [24]. Among these Nox isoforms, Nox2 and Nox4 are
largely expressed in the endothelium [6,25]. Nox2 has been found to be
involved in vascular inﬂammation and atherosclerotic lesion formation
[26], whereas Nox4 has been reported to play a protective role in
vascular function [27]. The current study extended our understanding
of NADPH oxidase by showing an aging-associated increase in Nox2
expression and a decrease in Nox4 expression in WT aging aortas. The
mirror image of Nox2 and Nox4 expressions in aging aortas were
accompanied by a signiﬁcant increase in ERK1/2 activation and
reduction in p38MAPK activation. Although the redox-signaling path-
ways underlying vascular aging remain unclear, it is possible that Nox2
signaling through ERK1/2 is involved in aging-associated deterioration
of endothelial function. However, in the absence of Nox2, we found a
signiﬁcant increase of Nox4 expression in aging Nox2KO aorta, which
might be a compensatory response. Compensatory increase in Nox4 in
the deﬁciency of Nox2 had been reported previously in endothelial cells
Fig. 6. Metabolic disorder-induced Nox2 activation and endothelial dysfunction in high fat-diet (HFD)-induced obesity and insulin-resistance treated with or without apocynin. A)
Metabolic measurements. B) Immunoﬂuorescence detection of Nox2 (green) in aortic wall sections. The endothelium was labelled with CD31 (red). Endothelial expression of Nox2 was
indicated by the yellow ﬂuorescence. C) Aorta ROS production detected by lucigenin-chemiluminescence and SOD-inhibitable Cytochrome c reduction assay. *P< 0.05 for HFD values
versus control (Ctl) values after dietary intervention. †P<0.05 for indicated values versus HFD values after dietary intervention. D) Endothelium-dependent vessel relaxation response to
acetylcholine (Ach). *P< 0.05 for signiﬁcant diﬀerence between two values (area under curve). n =9 mice/per group.
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[28,29]. Although skeletal muscle atrophy and reduced strength are
common inevitable features of aging [30], Nox2 is not involved because
knockout of Nox2 had no signiﬁcant eﬀect on the amount of O2.-
production by skeletal muscles regardless of age.
In summary, we have reported in the current study a crucial role for
Nox2-containing NADPH oxidase activation in response to aging-
associated metabolic disorders in mediating systemic oxidative stress
and oxidative damage of endothelial function and insulin receptor
function. Inhibition or knockout of Nox2 preserves endothelial function
and delays vascular aging.
A) ROS production
B) Nox2 and p53 expression
C) Endothelial cell senescence and apoptosis
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Fig. 7. High glucose and insulin-induced Nox2 activation and stress signaling in cell senescence and apoptosis in primary coronary microvascular endothelial cells. A) Lucigenin
chemiluminescence. Tiron was used to conﬁrm the detection of O2.-. Right panel: The eﬀects of diﬀerent enzyme inhibitors on high glucose and insulin (G+I)-induced O2.- production by
WT CMEC. *P< 0.05 for indicated values versus WT G+I value. B) Western blot. C) Left panels: In situ DCF (green) ﬂuorescence detection of intracellular ROS production. Nuclei were
labelled with DAPI (blue). Left middle panels: Nox2 expression (FITC, green). Nuclei were labelled with propidium iodide (red). Right middle panels: Cell senescence was detected by
SAβG activity (blue) and visualised under light microscopy. Right panels: cell apoptosis detected by TUNEL assay. Apoptotic cells were labelled by the yellow ﬂuorescence. SAβG and
TUNEL positive cells were expressed as percentage of total cells. *P< 0.05 for indicated values versus control values in the same genetic groups. †P<0.05 for indicated values versus WT
G+I values. n =3 separate CMEC isolation/group. Six mice were used for each CMEC isolation.
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